Locking down shape-shifting spike protein aids development of COVID-19 vaccine

Publishing in the journal Nature, researchers from the Univ. of Texas at Austin, Moderna and the NIH explain how they developed the COVID-19 vaccine candidate mRNA-1273 and report strong positive results on its effectiveness in mice.